Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis

Abstract Bacterial vaginosis (BV) is the most commonly diagnosed vaginal infection in women of reproductive age, with most patients unaware that they have BV due to its asymptomatic nature. BV is a dysbiotic condition defined by a deviation from the healthy Lactobacillus dominance to a polymicrobial...

Full description

Bibliographic Details
Published in:	npj Biofilms and Microbiomes
Main Authors:	Emmanuel Amabebe, Madhuri Tatiparthy, Ananth K. Kammala, Lauren S. Richardson, Brandie D. Taylor, Surendra Sharma, Ramkumar Menon
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Online Access:	https://doi.org/10.1038/s41522-025-00748-0

Similar Items

Exofection by exosomes: A transient functional cargo transfer
by: Ramkumar Menon, et al.
Published: (2025-06-01)

Exosomal delivery of IL-10: Biodistribution, pharmacokinetics, and preterm birth prevention strategies
by: Brinley Harrington, et al.
Published: (2025-06-01)

The Human Vaginal Bacterial Biota and Bacterial Vaginosis
by: Sujatha Srinivasan, et al.
Published: (2008-01-01)

Vaginal Microbiomes Associated With Aerobic Vaginitis and Bacterial Vaginosis
by: Evelyn Kaambo, et al.
Published: (2018-03-01)

The evaluation of the clinical efficacy of Prodexyn vaginal suppositories in the treatment of recurrent bacterial vaginosis
by: D.G. Konkov, et al.
Published: (2024-12-01)

FREQUENCY OF BACTERIAL VAGINOSIS IN PATIENTS WITH VAGINAL DISCHARGE
by: Asia Habib, et al.
Published: (2016-04-01)

Vaginal microbiota in bacterial vaginosis. Aspects of diagnosis and therapy
by: A. M. Savicheva, et al.
Published: (2014-12-01)

Extracellular Traps in Patients Diagnosed With Bacterial Vaginosis, Trichomoniasis, Candidiasis, Noninfectious Vaginitis and Cytolytic Vaginosis
by: María G. Ramírez-Ledesma, et al.
Published: (2024-01-01)

Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
by: A. B. Khuraseva, et al.
Published: (2018-11-01)

Hygienic vulvo-vaginal habits, contraceptive use, and bacterial vaginosis
by: Luis Jesus Reyes Garcia
Published: (2024-03-01)

Vaginal formulations containing prebiotics and probiotics for treatment of bacterial vaginosis
by: Caixuan Wang, et al.
Published: (2022-11-01)

Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis
by: Ling Zongxin, et al.
Published: (2010-09-01)

Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis.
by: Sujatha Srinivasan, et al.
Published: (2010-04-01)

Association of Chlamydia trachomatis burden with the vaginal microbiota, bacterial vaginosis, and metronidazole treatment
by: Caleb M. Ardizzone, et al.
Published: (2023-12-01)

The problem of recurrent bacterial vaginosis: modern strategies
by: T.F. Tatarchuk, et al.
Published: (2023-03-01)

Recurrent bacterial vaginosis: possible ways of correction
by: N.F. Zakharenko, et al.
Published: (2021-11-01)

Comparative efficacy of oral and vaginal probiotics in reducing the recurrence of bacterial vaginosis: a double-blind clinical trial
by: Mahnaz Boroumand Rezazadeh, et al.
Published: (2024-10-01)

Differential PCR diagnosis of bacterial vaginosis, aerobic vaginitis and vulvovaginal candidiasis
by: T. I. Makhova, et al.
Published: (2022-06-01)

Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples
by: Hayden N. Brochu, et al.
Published: (2025-04-01)

From Stress to Survival: Trophoblast-Derived Extracellular Vesicle Proteome Captures Aspirin-Driven Cellular Reprogramming in a Preeclampsia Model
by: Vineet Mahajan, et al.
Published: (2026-05-01)

The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis.
by: Jade E Bilardi, et al.
Published: (2013-01-01)

Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy
by: Ananth K. Kammala, et al.
Published: (2023-08-01)

Vaginal biocenosis in pregnant women with recurrent bacterial vaginosis after treatment with recombinant human interferon alpha-2b
by: A. V. Podgornaya, et al.
Published: (2019-09-01)

Improving breast cancer treatments using pharmacomicrobiomics
by: Aswin Anand Pai, et al.
Published: (2025-02-01)

Pharmacomicrobiomics in precision cancer therapy: bench to bedside
by: Khanh Le Ngoc, et al.
Published: (2024-09-01)

Integration of pharmacogenomic and pharmacomicrobiomic data for personalized medicine
by: Muhammad Shamsuzzaman, et al.
Published: (2023-03-01)

Prevalence and Factors Related to Trichomoniasis, Candidal Vaginitis, and Bacterial Vaginosis in Northeast Iran
by: Mitra Salehi, et al.
Published: (2025-01-01)

Utility of Vaginal pH as Point of Care Test for Detection of Bacterial Vaginosis
Published: (2022-05-01)

Efficacy of metronidazole and miconazole vaginal co-formulation for bacterial vaginosis and vulvovaginal candidiasis
by: E.A. Markova
Published: (2020-09-01)

Vaginal Dysbiosis and Partial Bacterial Vaginosis: The Interpretation of the “Grey Zones” of Clinical Practice
by: Giuseppina Campisciano, et al.
Published: (2021-01-01)

Comparsion of the Effect of Lactobacillus Acidophilus Suppository and Metronidazol Vaginal Tablet on Bacterial Vaginosis
by: Asghar Mohamad Poorasl, et al.
Published: (2011-09-01)

Prevalence of bacterial vaginosis in Portuguese pregnant women and vaginal colonization by Gardnerella vaginalis
by: Daniela Machado, et al.
Published: (2017-08-01)

Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses
by: Sobel JD, et al.
Published: (2019-07-01)

Bacterial Vaginosis
by: Abdul Karim, et al.
Published: (2017-01-01)

Aerobic vaginitis, bacterial vaginosis, and vaginal candidiasis among women of reproductive age in Arba Minch, southern Ethiopia
by: Addis Aklilu, et al.
Published: (2024-04-01)

Efficacy of normalization of vaginal microbiota after antimicrobial treatment for bacterial vaginosis and bacterial vaginosis in pregnant women (results of the multicenter prospective non-interventional comparative study)
by: V.E. Radzinskiy, et al.
Published: (2021-09-01)

Optimization of treatment and prevention of recurrences of bacterial vaginosis in postmenopausal women
by: S.O. Ostafiichuk, et al.
Published: (2024-12-01)

The assessment of anti-recurrence efficacy of Prodexin in the treatment of bacterial vaginosis
by: D.G. Konkov, et al.
Published: (2025-05-01)

Probiotics reduce the recurrence of asymptomatic bacterial vaginosis in Chinese women
by: Rui Zhang, et al.
Published: (2025-03-01)

Personalized approach to the diagnosis and treatment of recurrent forms of bacterial vaginosis
by: Tatyana Yu. Pestrikova, et al.
Published: (2024-04-01)